354 related articles for article (PubMed ID: 11432666)
1. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
3. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
Moritani S; Sugihara H; Kushima R; Hattori T
Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series.
Kattoor J; Koriyama C; Akiba S; Itoh T; Ding S; Eizuru Y; Abraham EK; Chandralekha B; Amma NS; Nair MK
J Med Virol; 2002 Nov; 68(3):384-9. PubMed ID: 12226826
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma.
Szkaradkiewicz A; Majewski W; Wal M; Czyzak M; Majewski P; Bierła J; Kuch A
Virus Res; 2006 Jun; 118(1-2):115-9. PubMed ID: 16413625
[TBL] [Abstract][Full Text] [Related]
7. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
9. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between clinical and pathological lymph node evaluation in Epstein-Barr virus-associated gastric cancers.
Ojima H; Fukuda T; Nakajima T; Takenoshita S; Nagamachi Y
Anticancer Res; 1996; 16(5B):3081-4. PubMed ID: 8920771
[TBL] [Abstract][Full Text] [Related]
12. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
[TBL] [Abstract][Full Text] [Related]
13. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China.
Hao Z; Koriyama C; Akiba S; Li J; Luo X; Itoh T; Eizuru Y; Zou J
Oncol Rep; 2002; 9(6):1293-8. PubMed ID: 12375037
[TBL] [Abstract][Full Text] [Related]
15. [Significance of the expression of P53 protein and P21WAF1 protein in the gastric carcinoma tissues associated with Epstein-Barr virus (EBV) infections].
Qian J; Li DQ; Zhong F; Li ZX; Lu LC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):1-3. PubMed ID: 16642206
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus in gastric carcinomas with lymphoid stroma.
Chang MS; Kim WH; Kim CW; Kim YI
Histopathology; 2000 Oct; 37(4):309-15. PubMed ID: 11012737
[TBL] [Abstract][Full Text] [Related]
18. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.
Gulley ML; Pulitzer DR; Eagan PA; Schneider BG
Hum Pathol; 1996 Jan; 27(1):20-7. PubMed ID: 8543306
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Epstein-Barr virus-encoded RNA expression, apoptosis and lymphocytic infiltration in gastric carcinoma with lymphoid-rich stroma.
Cho MY; Kim TH; Yi SY; Jung WH; Park KH
Med Princ Pract; 2004; 13(6):353-60. PubMed ID: 15467311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
